A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

Actinium-225 is a targeted and highly-potent alpha emitter that holds promise for patients who do not respond to lutetium-177 therapy. Rahul Parikh, MD, PhD, of University of Kansas, shared his ...

Scientists report landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer.

An elevated result on the prostate-specific antigen (PSA) test, or symptoms such as urinary frequency or urgency, can be alarming. And while these signs can sometimes signal prostate cancer, thats not ...

The drug makes prostate cancer easier to detect and stage because it attaches to the cancer cells themselves. This marks the third PSMA‑targeted radiopharmaceutical manufactured at Huntsman Cancer ...

Irish and American researchers have identified a potential new way to counter treatment‑resistant prostate cancer by ...

Prostate cancer numbers are down, except for men in one group: those with advanced prostate cancer. What’s behind the rise in these cases?

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

Scientists in Dublin and Tampa, Florida have published a new strategy for treating radiation-resistant cancers.